Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;48(3):931-40.
doi: 10.1007/s12035-013-8478-7. Epub 2013 Jun 15.

Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice

Suhail Rasool  1 , Hilda Martinez-Coria, Saskia Milton, Charles G Glabe
Affiliations

Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice

Suhail Rasool et al. Mol Neurobiol. 2013 Dec.

Abstract

Accumulation of beta-amyloid (Aβ) is an important pathological event in Alzheimer's disease (AD). It is now well known that vaccination against fibrillar Aβ prevents amyloid accumulation and preserves cognitive function in transgenic mouse models. To study the effect of vaccination against generic oligomer epitopes, Aβ oligomers, islet amyloid polypeptide oligomers, random peptide oligomer (3A), and Aβ fibrils were used to vaccinate 3xTg-AD, which develop a progressive accumulation of plaques and cognitive impairment. Subcutaneous administration of these antigens markedly reduced total plaque load (Aβ burden) and improved cognitive function in the 3xTg-AD mouse brains as compared to controls. We demonstrated that vaccination with this nonhuman amyloid oligomer generated high titers of specifically antibodies recognizing Aβ oligomers, which in turn inhibited accumulation of Aβ pathology in mice. In addition to amyloid plaques, another hallmark of AD is tau pathology. It was found that there was a significant decline in the level of hyper-phosphorylated tau following vaccination. We have previously shown that immunization with 3A peptide improves cognitive function and clears amyloid plaques in Tg2576 mice, which provides a novel strategy of AD therapy. Here, we have shown that vaccination with 3A peptide in 3xTg-AD mice not only clears amyloid plaques but also extensively clears abnormal tau in brain.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. J Cell Sci. 1994 Apr;107 ( Pt 4):869-79 - PubMed
    1. Neurobiol Aging. 2002 Mar-Apr;23(2):231-5 - PubMed
    1. Traffic. 2002 Nov;3(11):763-70 - PubMed
    1. Science. 2003 Apr 18;300(5618):486-9 - PubMed
    1. J Neuropathol Exp Neurol. 2006 Nov;65(11):1040-8 - PubMed

MeSH terms

LinkOut - more resources